LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | CGP60474 | 10 | uM | LJP6 | 2 | G01 | 72 | hr | 1235 | 165 | 4277 | 0.0386 | -0.6751 |
MDA-MB-231 | CGP60474 | 10 | uM | LJP6 | 3 | G01 | 72 | hr | 1235 | 514 | 4583 | 0.1121 | -0.3713 |
MDA-MB-231 | CGP60474 | 10 | uM | LJP5 | 1 | F01 | 72 | hr | 1235 | 403 | 4474 | 0.0901 | -0.4532 |
MDA-MB-231 | CGP60474 | 10 | uM | LJP5 | 2 | F01 | 72 | hr | 1235 | 409 | 4578 | 0.0893 | -0.4431 |
MDA-MB-231 | CGP60474 | 10 | uM | LJP5 | 3 | F01 | 72 | hr | 1235 | 552 | 4929 | 0.1120 | -0.3323 |
MDA-MB-231 | PD173074 | 0.04 | uM | LJP6 | 1 | I12 | 72 | hr | 1235 | 4491 | 4355 | 1.0310 | 1.0339 |
MDA-MB-231 | PD173074 | 0.04 | uM | LJP6 | 2 | I12 | 72 | hr | 1235 | 4707 | 4277 | 1.1004 | 1.1098 |
MDA-MB-231 | PD173074 | 0.04 | uM | LJP6 | 3 | I12 | 72 | hr | 1235 | 4786 | 4583 | 1.0442 | 1.0463 |
MDA-MB-231 | PD173074 | 0.12 | uM | LJP6 | 1 | I11 | 72 | hr | 1235 | 4511 | 4355 | 1.0356 | 1.0389 |
MDA-MB-231 | PD173074 | 0.12 | uM | LJP6 | 2 | I11 | 72 | hr | 1235 | 4850 | 4277 | 1.1339 | 1.1453 |
MDA-MB-231 | PD173074 | 0.12 | uM | LJP6 | 3 | I11 | 72 | hr | 1235 | 4723 | 4583 | 1.0305 | 1.0320 |
MDA-MB-231 | PD173074 | 0.37 | uM | LJP6 | 1 | I10 | 72 | hr | 1235 | 4978 | 4355 | 1.1428 | 1.1524 |
MDA-MB-231 | PD173074 | 0.37 | uM | LJP6 | 2 | I10 | 72 | hr | 1235 | 5433 | 4277 | 1.2702 | 1.2857 |
MDA-MB-231 | PD173074 | 0.37 | uM | LJP6 | 3 | I10 | 72 | hr | 1235 | 4825 | 4583 | 1.0527 | 1.0551 |
MDA-MB-231 | PD173074 | 1.11 | uM | LJP6 | 1 | I09 | 72 | hr | 1235 | 4983 | 4355 | 1.1440 | 1.1536 |
MDA-MB-231 | PD173074 | 1.11 | uM | LJP6 | 2 | I09 | 72 | hr | 1235 | 5218 | 4277 | 1.2199 | 1.2347 |
MDA-MB-231 | PD173074 | 1.11 | uM | LJP6 | 3 | I09 | 72 | hr | 1235 | 4549 | 4583 | 0.9925 | 0.9921 |
MDA-MB-231 | PD173074 | 3.33 | uM | LJP6 | 1 | I08 | 72 | hr | 1235 | 4588 | 4355 | 1.0533 | 1.0579 |
MDA-MB-231 | PD173074 | 3.33 | uM | LJP6 | 2 | I08 | 72 | hr | 1235 | 4859 | 4277 | 1.1360 | 1.1476 |
MDA-MB-231 | PD173074 | 3.33 | uM | LJP6 | 3 | I08 | 72 | hr | 1235 | 4497 | 4583 | 0.9812 | 0.9800 |
MDA-MB-231 | PD173074 | 10 | uM | LJP6 | 1 | I07 | 72 | hr | 1235 | 1855 | 4355 | 0.4259 | 0.2504 |
MDA-MB-231 | PD173074 | 10 | uM | LJP6 | 2 | I07 | 72 | hr | 1235 | 1308 | 4277 | 0.3058 | 0.0321 |
MDA-MB-231 | PD173074 | 10 | uM | LJP6 | 3 | I07 | 72 | hr | 1235 | 1710 | 4583 | 0.3731 | 0.1873 |
MDA-MB-231 | Crizotinib | 0.04 | uM | LJP5 | 1 | A24 | 72 | hr | 1235 | 4487 | 4474 | 1.0027 | 1.0030 |
MDA-MB-231 | Crizotinib | 0.04 | uM | LJP5 | 2 | A24 | 72 | hr | 1235 | 4340 | 4578 | 0.9479 | 0.9442 |